Adam Lenkowsky - EVP, Chief Commercial Officer at Bristol Myers Squibb Co

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Commercial Officer
Stock Symbol
BMY, CELG-RI on NYSE, BMYMP on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Adam Lenkowsky since 4/23/2024

Holdings reported by Adam Lenkowsky for Bristol Myers Squibb Co

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Market Share Units 31.5K $1.67M $52.99 Mar 10, 2025 Direct Common Stock, $0.10 par value
Common Stock, $0.10 par value 12.4K $785K $63.11 Mar 10, 2025 Direct
Common Stock, $0.10 par value 6.65K $352K $52.99 May 1, 2024 Direct
Common Stock, $0.10 par value 4.53K $286K $63.11 Mar 10, 2025 BMS Savings and Investment Program
Common Stock, $0.10 par value 5.29K $280K $52.99 May 1, 2024 By Spouse
Common Stock, $0.10 par value 4.36K $231K $52.99 May 1, 2024 BMS Savings and Investment Program
Common Stock, $0.10 par value 2.28K $144K $63.11 Mar 10, 2025 By Spouse
Performance Shares 47.2K Mar 10, 2025 Direct Common Stock, $0.10 par value

Transactions reported by Adam Lenkowsky for Bristol Myers Squibb Co

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.